Gene copy number profiling of soft-tissue leiomyosarcomas by array-comparative genomic hybridization

Cancer Genetics and Cytogenetics

Volumn 169, Issue 2, 2006, Pages 94-101

  Larramendy, Marcelo L ^a,b   Kaur, Sippy ^a   Svarvar, Catarina ^c   Böhling, Tom ^a   Knuutila, Sakari ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b FACULTAD DE CIENCIAS NATURALES Y MUSEO   (Argentina)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME; CHROMOSOME DUPLICATION; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE FREQUENCY; GENE LOCATION; HUMAN; HUMAN TISSUE; LEIOMYOSARCOMA; MALE; ONCOGENE; OSTEOSARCOMA; PRIORITY JOURNAL; SOFT TISSUE SARCOMA; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; FEMALE; GENE DOSAGE; HUMANS; LEIOMYOSARCOMA; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SOFT TISSUE NEOPLASMS;

EID: 33748171176     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2006.01.008     Document Type: Article

References (43)

1. Enzinger F.M., and Weiss S.W. Leiomyosarcoma. In: Weiss S.W., and Goldblum J.R. (Eds). Soft-tissue tumors. 4th edition (2001), Mosby, St. Louis 727-748
2. Boghosian L., Dal Cin P., Turc-Carel C., Rao U., Karakousis C., Sait S.J., and Sandberg A.A. Three possible cytogenetic subgroups of leiomyosarcoma. Cancer Genet Cytogenet 43 (1989) 39-49
3. Han K., Lee W., Harris C.P., Simsiman R.C., Lee K., Kang C., and Meisner L.F. Comparison of chromosome aberrations in leiomyoma and leiomyosarcoma using FISH on archival tissues. Cancer Genet Cytogenet 74 (1994) 19-24
4. Mertens F., Fletcher C.D., Dal Cin P., De Wever I., Mandahl N., Mitelman F., Rosai J., Rydholm A., Sciot R., Tallini G., Van den Berghe H., Vanni R., and Willen H. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP study group. Chromosomes and morphology. Genes Chromosomes Cancer 22 (1998) 16-25
5. Schneider B.F., Lowell M.A., and Golden W.L. Cytogenetic abnormalities in primary bronchopulmonary leiomyosarcoma of childhood. Cancer Genet Cytogenet 105 (1998) 145-151
6. Sreekantaiah C., Davis J.R., and Sandberg A.A. Chromosomal abnormalities in leiomyosarcomas. Am J Pathol 142 (1993) 293-305
7. Mitelman F, Johansson B, Mertens F. Mitelman Database of Chromosome Aberrations in Cancer. Available at: http://www.cgap.nci.nih.gov/Chromosomes/Mitelman. Accessed July 14, 2005.
8. Derre J., Lagace R., Nicolas A., Mairal A., Chibon F., Coindre J.M., Terrier P., Sastre X., and Aurias A. Leiomyosarcomas and most malignant fibrous histiocytomas share very similar comparative genomic hybridization imbalances: an analysis of a series of 27 leiomyosarcomas. Lab Invest 81 (2001) 211-215
9. El-Rifai W., Sarlomo-Rikala M., Knuutila S., and Miettinen M. DNA copy number changes in development and progression in leiomyosarcomas of soft tissues. Am J Pathol 153 (1998) 985-990
10. Forus A., Weghuis D.O., Smeets D., Fodstad O., Myklebost O., and van Kessel A.G. Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21∼q22 in soft tissue sarcomas. Genes Chromosomes Cancer 14 (1995) 8-14
11. Hu J., Khanna V., Jones M., and Surti U. Genomic alterations in uterine leiomyosarcomas: potential markers for clinical diagnosis and prognosis. Genes Chromosomes Cancer 31 (2001) 117-124
12. Otano-Joos M., Mechtersheimer G., Ohl S., Wilgenbus K.K., Scheurlen W., Lehnert T., Willeke F., Otto H.F., Lichter P., and Joos S. Detection of chromosomal imbalances in leiomyosarcomas by comparative genomic hybridization and interphase cytogenetics. Cytogenet Cell Genet 90 (2000) 86-92
13. Parente F., Grosgeorge J., Coindre J.-M., Terrier P., Vilain O., and Turc-Carel C. Comparative genomic hybridization reveals novel chromosome deletions in 90 primary soft-tissue tumors. Cancer Genet Cytogenet 115 (1999) 89-95
14. Wang R., Lu Y.J., Fisher C., Bridge J.A., and Shipley J. Characterization of chromosome aberrations associated with soft-tissue leiomyosarcomas by twenty-four color karyotyping and comparative genomic hybridization analysis. Genes Chromosomes Cancer 31 (2001) 54-64
15. Wang R., Titley J.C., Lu Y.J., Summersgill B.M., Bridge J.A., Fisher C., and Shipley J. Loss of 13q14∼q21 and gain of 5p14∼pter in the progression of leiomyosarcoma. Mod Pathol 16 (2003) 778-785
16. Isola J., DeVries S., Chu L., Ghazvini S., and Waldman F. Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. Am J Pathol 145 (1994) 1301-1308
17. El-Rifai W., Larramendy M.L., Björkqvist A.-M., Hemmer S., and Knuutila S. Optimization of comparative genomic hybridization using fluorochrome conjugated to dCTP and dUTP nucleotides. Lab Invest 77 (1997) 699-700
18. Larramendy M.L., El-Rifai W., and Knuutila S. Comparison of fluorescein isothiocyanate- and Texas red-conjugated nucleotides for direct labeling in comparative genomic hybridization. Cytometry 31 (1998) 174-179
19. Knuutila S., Armengol G., Björkqvist A.-M., El-Rifai W., Larramendy M.L., Monni O., and Szymanska J. Comparative genomic hybridization study on pooled DNA from tumors of one clinical-pathological entity. Cancer Genet Cytogenet 100 (1998) 25-30
20. Kallioniemi O.-P., Kallioniemi A., Piper J., Isola J., Waldman F.M., Gray J.W., and Pinkel D. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10 (1994) 231-243
21. Atiye J., Wolf M., Kaur S., Monni O., Böhling T., Kivioja A., Serra M., Tas E., Tarkkanen M., and Knuutila S. Gene amplifications in osteosarcoma - CGH microarray analysis. Genes Chromosomes Cancer 42 (2005) 158-163
22. Hyman E., Kauraniemi P., Hautaniemi S., Wolf M., Mousses S., Rozenblum R., Ringner M., Sauter G., Monni O., Elkahloun A., Kallioniemi O.-P., and Kallioniemi A. Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res 62 (2002) 6240-6245
23. Jong K, Marchiori E, van der Vaart A, Ylstra B, Weiss M, Meijer G. Chromosomal breakpoint detection in human cancer. In: Cagnoni S, Romero Cardalda JJ, Corne DW, Gottlieb J, Guillot A, Hart E, Johnson CG, Marchiori E, Meyer J-A, Middendorf M, Raidl GR, editors. Applications of evolutionary computing. EvoWorkshops 2003: EvoBIO, EvoCOP, EvoIASP, EvoMUSART, EvoROB, and EvoSTIM, Essex, UK, April 14-16, 2003. Proceedings. Berlin: Springer-Verlag GmbH, 2003, pp. 54-65.
24. Craig D.W., Huentelman M.J., Hu-Lince D., Zismann V.L., Kruer M.C., Lee A.M., Puffenberger E.G., Pearson J.M., and Stephan D.A. Identification of disease causing loci using an array-based genotyping approach on pooled DNA. BMC Genomics 6 (2005) 138
25. Kendziorski C., Irizarry R.A., Chen K.-S., Haag J.D., and Gould M.N. On the utility of pooling biological samples in microarray experiments. Proc Natl Acad Sci USA 102 (2005) 4252-4257
26. Zhang S.-D., and Gant T.W. Effect of pooling samples on the efficiency of comparative studies using microarrays. Bioinformatics 21 (2005) 4378-4383
27. Knuutila S., Björkqvist A.-M., Autio K., Tarkkanen M., Wolf M., Monni O., Szymanska J., Larramendy M.L., Tapper J., Pere H., El-Rifai W., Hemmer S., Wasenius V.-M., Vidgren V., and Zhu Y. DNA copy number amplifications in human neoplasms. Review of comparative genomic hybridization studies. Am J Pathol 152 (1998) 1107-1123
28. Knuutila S., Aalto Y., Autio K., Björkqvist A.-M., El-Rifai W., Hemmer S., Huhta T., Kettunen E., Kiuru-Kuhlefelt S., Larramendy M.L., Lushnikova T., Monni O., Pere H., Tapper J., Tarkkanen M., Varis A., Wasenius V.-M., Wolf M., and Zhu Y. DNA copy number losses in human neoplasms. Review. Am J Pathol 155 (1999) 683-694
29. Wolf M., Tarkkanen M., Hulsebos T., Larramendy M.L., Forus A., Myklebost O., Aaltonen L.A., Elomaa I., and Knuutila S. Characterization of the 17p amplicon in human sarcomas: microsatellite marker analysis. Int J Cancer 82 (1999) 329-333
30. Skubitz K.M., and Skubitz A.P. Differential gene expression in leiomyosarcoma. Cancer 98 (2003) 1029-1038
31. Forus A., Berner J.-M., Meza-Zepeda L.A., Saeter G., Mischke D., Fodstad Ø., and Myklebost O. Molecular characterization of a novel amplicon at 1q21∼q22 frequently observed in human sarcomas. Br J Cancer 78 (1998) 495-503
32. Komatsu K., Andoh A., Ishiguro S., Suzuki N., Hunai H., Kobune-Fujiwara Y., Kameyama M., Miyoshi J., Akedo H., and Nakamura H. Increased expression of S100A6 (calcyclin), a calcium-binding protein of the S100 family, in human colorectal adenocarcinomas. Clin Cancer Res 6 (2000) 172-177
33. Bieche I., and Lidereau R. A gene dosage effect is responsible for high overexpression of the MUC1 gene observed in human breast tumors. Cancer Genet Cytogenet 98 (1997) 75-80
34. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S.I., Puc J., Miliaresis C., Rodgers L., McCombie R., Bigner S.H., Giovanella B.C., Ittmann M., Tycko B., Hibshoosh H., Wigler M.H., and Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275 (1997) 1943-1947
35. Quade B.J., Pinto A.P., Howard D.R., Peters III W.A., and Crum C.P. Frequent loss of heterozygosity for chromosome 10 in uterine leiomyosarcoma in contrast to leiomyoma. Am J Pathol 154 (1999) 945-950
36. Whang Y.E., Wu X., Suzuki H., Reiter R.E., Tran C., Vessella R.L., Said J.W., Isaacs W.B., and Sawyers C.L. Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proc Natl Acad Sci U S A 95 (1998) 5246-5250
37. Davies M.P., Gibbs F.E., Halliwell N., Joyce K.A., Roebuck M.M., Rossi M.L., Salisbury J., Sibson D.R., Tacconi L., and Walker C. Mutation in the PTEN/MMAC1 gene in archival low-grade and high-grade gliomas. Br J Cancer 79 (1999) 1542-1548
38. Tashiro H., Blazes M.S., Wu R., Cho K.R., Bose S., Wang S.I., Li J., Parsons R., and Ellenson L.H. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res 57 (1997) 3935-3940
39. Rhei E., Kang L., Bogomolniy F., Federici M.G., Borgen P.I., and Boyd J. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res 57 (1997) 3657-3659
40. Wechsler D.S., Shelly C.A., and Dang C.V. Genomic organization of human MXI1, a putative tumor suppressor gene. Genomics 32 (1996) 466-470
41. Taj M.M., Tawil R.J., Engstrom L.D., Zeng Z., Hwang C., Sanda M.G., and Wechsler D.S. Mxil, a Myc antagonist, suppresses proliferation of DU145 human prostate cells. Prostate 47 (2001) 194-204
42. Rao U.N., Bakker A., Swalsky P.A., and Finkelstein S.D. Max interacting protein 1: loss of heterozygosity is frequent in desmoplastic melanoma. Mod Pathol 12 (1999) 344-350
43. Henriksen J., Aagesen T.H., Maelandsmo G.M., Lothe R.A., Myklebost O., and Forus A. Amplification and overexpression of COPS3 in osteosarcomas potentially target TP53 for proteasome-mediated degradation. Oncogene 22 (2003) 5358-5361